- Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience
-
Chong YP, Kim S, Ko OB, Koo JE, Lee D, Park SH, Park SJ, Lee D, Kim SW, Suh C
- KMID: 1783067
- J Korean Med Sci.
- 2008 Oct;23(5):819-824.
- doi: 10.3346/jkms.2008.23.5.819
Immunoglobulin (Ig) D multiple myeloma (MM) accounts for 2% of all MM cases and has been reported to be associated with poor prognosis compared with other MM subtypes. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
